Sterling Investment Advisors Ltd. Boosts Stake in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS)

Sterling Investment Advisors Ltd. grew its position in shares of Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 5.7% during the fourth quarter, Holdings Channel reports. The fund owned 167,703 shares of the company’s stock after purchasing an additional 9,008 shares during the period. Tema Cardiovascular and Metabolics ETF makes up about 1.2% of Sterling Investment Advisors Ltd.’s holdings, making the stock its 24th biggest holding. Sterling Investment Advisors Ltd. owned 0.07% of Tema Cardiovascular and Metabolics ETF worth $4,842,000 as of its most recent filing with the SEC.

Tema Cardiovascular and Metabolics ETF Stock Performance

HRTS stock opened at $30.66 on Tuesday. Tema Cardiovascular and Metabolics ETF has a fifty-two week low of $28.56 and a fifty-two week high of $36.03. The business’s 50 day moving average price is $29.74 and its two-hundred day moving average price is $32.11. The company has a market capitalization of $70.52 million, a price-to-earnings ratio of 32.89 and a beta of 0.93.

Tema Cardiovascular and Metabolics ETF Announces Dividend

The firm also recently disclosed a dividend, which was paid on Thursday, December 12th. Investors of record on Wednesday, December 11th were given a $0.4693 dividend. The ex-dividend date was Wednesday, December 11th.

Tema Cardiovascular and Metabolics ETF Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.